Bionano Genomics, Inc. (BNGO) Sof marja

BNGO (Bionano Genomics) - kompaniyaning tovar belgisi

Bionano Genomics, Inc. (BNGO) laboratoriyalar bilan strategik ittifoqlar va AI ning joriy etilishi orqali DNK tahlilini kengaytirmoqda. Saphyr ning texnologik ustunligi va patent himoyasi raqobatchilar uchun kirishning sezilarli to'sig'ini yaratadi. Bozor kapitalizatsiyasi apparat va dasturiy ta'minotning joriy etilishiga asoslangan. GURU.Markets terminali grafigidagi sof savdo rentabelligi ko'rsatkichi -96.90 darajasida ekanligini ko'rsatmoqda.

bionanogenomics.com (BNGO) - Kompaniya sotuv marjasi 04.07.2022dan 20.11.2026gacha

Bionano Genomics Inc. (BNGO) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:Bionano Genomics - BNGO
Bionano Genomics ishlab chiqargan mahsulot

Sotuv marjalari aktivlarning stress-testlari davomida haqiqiy daromadlilikni baholash uchun asosiy filtr vazifasini o'taydi. Ushbu ko'rsatkich umumiy tushumda sof foydaning ulushini o'lchab, xarajatlarni boshqarishning yakuniy samaradorligini namoyish etadi. Sof marja dinamikasini tahlil qilish orqali investor Bionano Genomics, Inc. (BNGO) kompaniyasining uskunalar va dasturiy ta'minot yetkazib berishni monetizatsiya qilish qobiliyatini ko'rishi mumkin. Ushbu ko'rsatkichning oshishi genom xaritalash tizimlari uchun ishlab chiqarish xarajatlarining optimallashtirilganini tasdiqlaydi, kamayishi esa yuqori texnologik mahsulotlarni joriy etishda xarajatlarning ortayotganidan dalolat beradi.

Bionano Genomics, Inc. (BNGO) raqobatchilari

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|LXEO: Sotuvning sof marjinal rentabelligi|Korro Bio Inc. - Sof foyda normasi|EDIT (editasmedicine.com) - Sotuvning sof marjinal rentabelligi|Sof marja SLN|Sof marja ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning sof rentabelligi|Sof marja Sangamo SGMO|NAUT: Sotuvning sof rentabelligi|MGX: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Precision BioSciences|GBIO (generationbio.com) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi IMNN (Imunon, Inc.)|Sotuvning sof marjinal rentabelligi PHIO|MBIO - Sof marja|Sotuvning sof marjinal rentabelligi RNAZ (TransCode Therapeutics)|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX